Results

Total Results: 1,112 records

Showing results for "phase".

  1. TND-0543_05-24-2013 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0543_05-24-2013.pdf
    January 01, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
    January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
    January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0416_02-18-2011.pdf
    January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  5. effectivehealthcare.ahrq.gov/products/wiki-collaboration/research
    September 30, 2011 - Feasibility Study of a Wiki Collaboration Platform for Systematic Reviews Research Report September 30, 2011 Web Version [NLM Site] Download Main Document PDF 643.7 KB People using assistive technology may not be able to fully access information in this file. For additional assistance, please contact u…
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0620_131115.pdf
    March 13, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  7. effectivehealthcare.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
    April 24, 2015 - adrenergic agonist Increases bladder capacity by relaxing the bladdersmooth muscle during the storage phase … random allocation/ double blind method/ single blind method/ clinical trial/ clinical trial, phase … clinical trial, phase ii.pt. clinical trial, phase iii.pt. clinical trial, phase iv.pt. … Effects and Adverse Reactions"/ exp Adverse Drug Reaction Reporting Systems/ exp Clinical Trials, Phase … Effects and Adverse Reactions"/ exp Adverse Drug Reaction Reporting Systems/ exp Clinical Trials, Phase
  8. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the one topic for which (1) preliminary phase III data for drugs were … Phase III trials conducted to obtain FDA approval reported that patients with SBS treated with teduglutide … Of the 566 subjects, 173 subjects were treated in Phase 3 SBS studies (134/173 [77%] at the dose of … Phase 3 Gattex (teduglutide) data highlight potential new treatment for adults with short bowel syndrome
  9. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the two topics for which (1) preliminary phase III data for drugs were … this period, primarily due to failure to meet stated endpoints or demonstrate treatment efficacy in phase … and two beta-amyloid precursor protein site–cleaving enzyme (BACE) inhibitors, currently in late-phase … The latter cooperative sponsors the largest ongoing trial, a phase II/III trial investigating intranasal
  10. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or … Recently completed unphased, phase II, and phase IV clinical studies reported that daily oral zonisamide … In a phase III trial sponsored by the University of Pittsburgh (Pittsburgh, PA) and its affiliated … , a University of Pittsburgh (Pittsburgh, PA)-based research group reported results from a larger phase
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
    May 27, 2010 - The reference is: First results of a phase III multicenter randomized controlled trial of intensity … All three randomized studies, as well as all phase II-like and retrospective comparisons, report improved … Besides careful phase I-II studies of dose escalation, a policy of delivering higher doses using IMRT … In addition, two phase III RTOG trials (0522 and 0234) have 3DRT and IMRT treatment populations which … Besides careful phase I-II studies of dose escalation, a policy of delivering higher doses using
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0368_11-08-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0367_11-08-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0129_07-13-2009.pdf
    January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  15. effectivehealthcare.ahrq.gov/products/distributed-network-expansion/research
    April 03, 2012 - The enhancements described below will be incorporated into Phase 2 of our Distributed Research Network … We designated this activity as Phase 1.5, to distinguish it from the task order that ended in August … Our approach was based on lessons learned from Phase 1 of DRN and specifically on our findings that a … Data Mart Client Functions Workflow Manager— In this phase, the Data Mart Client was extended so that … Document Scope This document describes the functional requirements and design for DRN phase 1.5.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - In adverse event analysis, page 45, why weren't open label run-in phase data in the withdrawal studies … This was a 3- phase study (Period A) was a 4-month, open-label phase that determined response to abatacept … The second phase (Period B) was a 6-month, randomized, double-blind, parallel-dosing, placebo-controlled … During the double-blind phase (Period B), serious adverse events occurred in two patients in the placebo … E.g., the etanercept study (Lovell, et al.) used an active run-in phase before randomization.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0710-140625.pdf
    January 08, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0313_02-09-2009.pdf
    January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
    January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0311_06-17-2008.pdf
    January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: